Liver Toxicity halts Clinical Trial of IAP Antagonist for Advanced Solid Tumors

Liver Toxicity halts Clinical Trial of IAP Antagonist for Advanced Solid Tumors Curator: Stephen J. Williams, Ph.D. UPDATED 8/12/2022 Athough not related to IAP Antagonists this update does report 2 deaths from IDILI or idiosynchratic drug induced liver injury from a gene therapy trial using an AAV (adeno associated virus) targeting the disease spinal muscular … Continue reading Liver Toxicity halts Clinical Trial of IAP Antagonist for Advanced Solid Tumors